Lufthansa (LHAG.DE) will allow passengers to use new digital COVID-19 vaccination certificates at check-in for their flights, the German airline said on Thursday.
Here’s what you need to know about the coronavirus right now.
Here’s what you need to know about the coronavirus right now.
Japan’s economy likely grew and avoided slipping into recession this quarter but an extension of emergency measures to stem a rise in coronavirus infections has dented the growth outlook, a Reuters poll showed.
Here’s what you need to know about the coronavirus right now.
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer (PFE.N) coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.
Here’s what you need to know about the coronavirus right now.
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to treat Alzheimer’s disease could reinvigorate investor interest more broadly in biotech and pharmaceutical shares that have struggled in 2021.
U.S. regulators on Monday approved Biogen Inc’s (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease despite controversy over whether the clinical evidence proves the drug works, sending its shares soaring.
Urban Indians are getting COVID-19 shots much faster than the
Lufthansa (LHAG.DE) will allow passengers to use new digital COVID-19 vaccination certificates at check-in for their flights, the German airline said on Thursday.
Here’s what you need to know about the coronavirus right now.
Here’s what you need to know about the coronavirus right now.
Japan’s economy likely grew and avoided slipping into recession this quarter but an extension of emergency measures to stem a rise in coronavirus infections has dented the growth outlook, a Reuters poll showed.
Here’s what you need to know about the coronavirus right now.
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer (PFE.N) coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.
Here’s what you need to know about the coronavirus right now.
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to treat Alzheimer’s disease could reinvigorate investor interest more broadly in biotech and pharmaceutical shares that have struggled in 2021.
U.S. regulators on Monday approved Biogen Inc’s (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease despite controversy over whether the clinical evidence proves the drug works, sending its shares soaring.
Urban Indians are getting COVID-19 shots much faster than the
© | All rights reserved.
